Appendiceal neoplasm
Therapeutic area
Gastroenterology
Rare disease
No
- Definition
- A benign or malignant neoplasm involving the appendix.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Appendiceal neoplasm
- Therapeutic area
- Gastroenterology
- appendiceal neoplasm
- Appendiceal Cancer
- Appendiceal Cancers
- Appendiceal Neoplasms
- appendix neoplasm
- appendix tumor
- Appendix Tumors
- appendix tumour
- Cancer, Appendiceal
- neoplasm of appendix
- neoplasm of the appendix
- neoplasm of vermiform appendix
- tumor of appendix
- tumor of the appendix
- tumor of vermiform appendix
- tumour of appendix
- tumour of the appendix
- tumour of vermiform appendix
- vermiform appendix neoplasm
- vermiform appendix neoplasm (disease)
- vermiform appendix tumor
- vermiform appendix tumour
- Severity
- Severe
- Gastroenterology
- Oncology
Sources for recorded values
- MONDO ID
- MONDO:0001236
- Parent condition
- MONDO:0005694
Related records
Broader conditions (18)
- Cancer or benign tumor
- Cecal disorder
- Cecal neoplasm
- Colonic disorder
- Colonic neoplasm
- Colorectal neoplasm
- Digestive system disorder
- Digestive system neoplasm
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Disorder of appendix
- Human disease
- Intestinal disorder
- Intestinal neoplasm
- Large intestine disorder
- Neoplasm
- Neoplastic disease or syndrome
Narrower conditions (19)
- Appendix adenocarcinoma
- Appendix adenoma
- Appendix cancer
- Appendix carcinoma
- Appendix L-cell glucagon-like peptide-producing neuroendocrine tumor
- Appendix leiomyoma
- Appendix lymphoma
- Appendix mucinous cystadenocarcinoma
- Appendix neuroendocrine neoplasm
- Appendix neuroendocrine tumor G1
- Appendix villous adenoma
- Benign neoplasm of appendix
- Carcinoma in situ of appendix
- Classic neuroendocrine tumor of appendix
- Epithelial tumor of the appendix
- Goblet cell carcinoma
- Mucinous adenocarcinoma of the appendix
- Neuroendocrine tumor of the appendix, well differentiated, low or intermediate grade
- Pseudomyxoma peritonei
Trials (85)
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
- A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis
- A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
- Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
- Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
- Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
- Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
- Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis
- Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei
- Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
- Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
- Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms
- Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
- Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients
- EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
- Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
- Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC